Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1991-3-28
|
pubmed:abstractText |
Reduction of pulmonary vascular resistance by a high inspired oxygen concentration is a common, but not universal phenomenon in patients with pulmonary vascular disease of varying etiology that may determine their response to long-term domiciliary oxygen therapy. We therefore determined changes in PVR during oxygen therapy in two patient populations not previously studied: systemic sclerosis (n = 8, mean age +/- SEM, 44.5 +/- 5.4 years) and primary pulmonary hypertension (n = 7, mean age +/- SEM 38 +/- 7.8 years). All patients were hypoxemic (arterial oxygen tension, on air 9.5 +/- 1.2 kPa for SSc and 8.3 +/- 0.6 kPa for PPH, p greater than 0.05). Right atrial pressure, pulmonary artery pressure, pulmonary artery occlusion pressure, systemic arterial pressure, PaO2 and cardiac output by thermodilution were measured at three, 20-min intervals while inspiring air and again after inspiring 60 percent oxygen for 30 min. The PVR fell significantly with oxygen in patients with SSc from 797.6 +/- 179.2 to 610 +/- 151.6 dynes/s/cm-5 (p less than 0.01), and this fall correlated with baseline PAP and PaO2 prior to oxygen therapy (r = 0.86, p less than 0.025; r = 0.77, p less than 0.05, respectively). In patients with PPH, there was no significant fall in PVR with oxygen (from 969 +/- 80.2 to 851.9 +/- 91.2 dynes/s/cm-5, p greater than 0.05) and no predictor of a vasodilator response in individual patients. In SSc, hypoxic pulmonary vasoconstriction contributes more consistently to elevated PVR than in patients with PPH.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0012-3692
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
551-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1899817-Adult,
pubmed-meshheading:1899817-Anoxia,
pubmed-meshheading:1899817-Blood Pressure,
pubmed-meshheading:1899817-Carbon Dioxide,
pubmed-meshheading:1899817-Cardiac Output,
pubmed-meshheading:1899817-Female,
pubmed-meshheading:1899817-Humans,
pubmed-meshheading:1899817-Hypertension, Pulmonary,
pubmed-meshheading:1899817-Lung,
pubmed-meshheading:1899817-Male,
pubmed-meshheading:1899817-Middle Aged,
pubmed-meshheading:1899817-Oxygen,
pubmed-meshheading:1899817-Oxygen Inhalation Therapy,
pubmed-meshheading:1899817-Pulmonary Artery,
pubmed-meshheading:1899817-Scleroderma, Systemic,
pubmed-meshheading:1899817-Vascular Resistance,
pubmed-meshheading:1899817-Vasoconstriction
|
pubmed:year |
1991
|
pubmed:articleTitle |
Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.
|
pubmed:affiliation |
Department of Thoracic Medicine, National Heart and Lung Institute, London, England.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|